Compile Data Set for Download or QSAR
maximum 50k data
Found 231 Enz. Inhib. hit(s) with all data for entry = 7244
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183589(US9145354, 241)
Affinity DataIC50:  36nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183547(US9145354, 182)
Affinity DataIC50:  38nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183530(US9145354, 157)
Affinity DataIC50:  45nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183490(US9145354, 97)
Affinity DataIC50:  47nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183527(US9145354, 152)
Affinity DataIC50:  51nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183469(US9145354, 69)
Affinity DataIC50:  52nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183540(US9145354, 171)
Affinity DataIC50:  56nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183480(US9145354, 84)
Affinity DataIC50:  57nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183434(US9145354, 32)
Affinity DataIC50:  58nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183481(US9145354, 85)
Affinity DataIC50:  61nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183545(US9145354, 179)
Affinity DataIC50:  63nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183631(US9145354, 298)
Affinity DataIC50:  64nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183636(US9145354, 303)
Affinity DataIC50:  65nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM60671(BDBM183487 | US9145354, 92)
Affinity DataIC50:  66nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183526(US9145354, 150)
Affinity DataIC50:  68nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183497(US9145354, 108)
Affinity DataIC50:  70nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM60669(US9145354, 24)
Affinity DataIC50:  75nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183413(US9145354, 9)
Affinity DataIC50:  76nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183493(US9145354, 103)
Affinity DataIC50:  77nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183562(US9145354, 200)
Affinity DataIC50:  78nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183577(US9145354, 224)
Affinity DataIC50:  81nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183489(US9145354, 95)
Affinity DataIC50:  85nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183514(US9145354, 134)
Affinity DataIC50:  85nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM60704(BDBM183583 | US9145354, 220 | US9145354, 267)
Affinity DataIC50:  85nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183544(US9145354, 178)
Affinity DataIC50:  88nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183405(US9145354, 1)
Affinity DataIC50:  89nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM60668(BDBM183408 | US9145354, 23)
Affinity DataIC50:  89nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183501(US9145354, 113)
Affinity DataIC50:  93nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183570(US9145354, 212)
Affinity DataIC50:  94nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183596(US9145354, 250)
Affinity DataIC50:  95nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183537(US9145354, 167)
Affinity DataIC50:  98nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183569(US9145354, 210)
Affinity DataIC50:  98nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM60668(BDBM183408 | US9145354, 23)
Affinity DataIC50:  110nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183492(US9145354, 101)
Affinity DataIC50:  110nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183495(US9145354, 106)
Affinity DataIC50:  110nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183551(US9145354, 186)
Affinity DataIC50:  110nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183586(US9145354, 238)
Affinity DataIC50:  110nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM60723(BDBM183602 | US9145354, 268)
Affinity DataIC50:  110nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183605(US9145354, 263)
Affinity DataIC50:  110nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183612(US9145354, 276)
Affinity DataIC50:  110nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183513(US9145354, 133)
Affinity DataIC50:  120nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183506(US9145354, 125 | US9145354, 126 | US9145354, 127)
Affinity DataIC50:  120nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183503(US9145354, 119)
Affinity DataIC50:  120nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183542(US9145354, 173)
Affinity DataIC50:  130nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183415(US9145354, 11)
Affinity DataIC50:  130nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183619(US9145354, 286)
Affinity DataIC50:  130nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183584(US9145354, 235)
Affinity DataIC50:  130nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183486(US9145354, 90)
Affinity DataIC50:  130nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM183611(US9145354, 275)
Affinity DataIC50:  130nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Astex Therapeutics

US Patent
LigandPNGBDBM60719(BDBM183478 | US9145354, 265)
Affinity DataIC50:  130nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 231 total ) | Next | Last >>
Jump to: